Sorting the hype from the facts in melanoma.
作者信息
Autier P, Boyle P, Doré J F
出版信息
Lancet. 1998 Aug 29;352(9129):738-9. doi: 10.1016/S0140-6736(05)60857-4.
PMID:9729018
Abstract
摘要
相似文献
1
Sorting the hype from the facts in melanoma.区分黑色素瘤中的炒作与事实。
Lancet. 1998 Aug 29;352(9129):738-9. doi: 10.1016/S0140-6736(05)60857-4.
2
Adjuvant therapy of melanoma.黑色素瘤的辅助治疗
Lancet. 1998 Aug 29;352(9129):737-8. doi: 10.1016/S0140-6736(05)60856-2.
3
Adjuvant interferon in the treatment of melanoma.辅助性干扰素治疗黑色素瘤
Br J Cancer. 1999 Aug;80(11):1679-80. doi: 10.1038/sj.bjc.6690582.
4
Adjuvant interferon alfa-2b for high-risk melanoma.
J Clin Oncol. 1996 Jun;14(6):1968-9. doi: 10.1200/JCO.1996.14.6.1968.
5
Adjuvant IFN alpha2 therapy of melanoma.
Lancet. 1998 Jun 27;351(9120):1901-3. doi: 10.1016/S0140-6736(05)78608-6.
6
Clinical prognostic factors in adjuvant melanoma trial.
J Clin Oncol. 1996 Jun;14(6):1967-8. doi: 10.1200/JCO.1996.14.6.1967.
7
Interferon adjuvant therapy of melanoma.黑色素瘤的干扰素辅助治疗。
Cancer. 1997 May 1;79(9):1843-6. doi: 10.1002/(sici)1097-0142(19970501)79:9<1843::aid-cncr33>3.0.co;2-w.
8
Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma.类风湿性关节炎并发恶性黑色素瘤的辅助性α干扰素治疗
J Rheumatol. 1999 Apr;26(4):1009-10.
9
[High-dose interferon-alpha and adjuvant treatment of melanoma with poor prognosis: requiem for a drug marketing license?].[高剂量干扰素-α与预后不良黑色素瘤的辅助治疗：药物上市许可的挽歌？]
Ann Dermatol Venereol. 1999 Mar;126(3):211-3.
10
Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma.恶性黑色素瘤辅助性干扰素α-2b治疗期间严重视力丧失。
Lancet. 1999 Apr 17;353(9161):1326. doi: 10.1016/S0140-6736(99)00403-1.
Zotero 插件